Deals

Insilico Medicine Strikes Tens‑of‑Millions‑of‑Dollars AI Collaboration with Frontier Foundation Model Lab – MMAI Gym Framework to Power Generative Biology Models
AIHKG: 3696

Insilico Medicine Strikes Tens‑of‑Millions‑of‑Dollars AI Collaboration with Frontier Foundation Model Lab – MMAI Gym Framework to Power Generative Biology Models

Insilico Medicine (HKG: 3696) announced it has entered into a collaboration agreement worth tens of millions of dollars with a frontier foundation model laboratory to jointly develop, validate, and commercialize…

Qilu Pharmaceutical Drops RMB 400 Million Equity Stake in TYK Medicines – But TY‑9591 Licensing and China Commercialization Deal Stays Alive

Qilu Pharmaceutical Drops RMB 400 Million Equity Stake in TYK Medicines – But TY‑9591 Licensing and China Commercialization Deal Stays Alive

Medicovestor Completes Seed Funding Round to Advance Next-Generation Antibody and ADC Pipeline – MC004 Naked Antibody Targets FDA IND Filing by Early 2027

Medicovestor Completes Seed Funding Round to Advance Next-Generation Antibody and ADC Pipeline – MC004 Naked Antibody Targets FDA IND Filing by Early 2027

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Adagene Expands Exelixis Collaboration to Include Third Target Using SAFEbody Technology
AdageneADC / XDC

Adagene Expands Exelixis Collaboration to Include Third Target Using SAFEbody Technology

Ollin Biosciences Launches With $100M Funding to Advance Ophthalmology Pipeline
Multi-specific antibodiesOllin Biosciences

Ollin Biosciences Launches With $100M Funding to Advance Ophthalmology Pipeline

Yanyin Tech and CirCode Biomed Forge Three-Year RNA Drug Development Partnership
AICircode Bio

Yanyin Tech and CirCode Biomed Forge Three-Year RNA Drug Development Partnership

China Resources Double-Crane Partners with Rigerna on siRNA Drug RG008 for Chronic Metabolic Diseases
China Resources Double-Crane PharmaceuticalRigerna Therapeutics

China Resources Double-Crane Partners with Rigerna on siRNA Drug RG008 for Chronic Metabolic Diseases

Show More